MSA
Marino Stram & Associates’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $238K | Buy |
6,208
+39
| +0.6% | +$1.5K | 0.05% | 161 |
|
|
2025
Q1 | $239K | Buy |
6,169
+42
| +0.7% | +$1.63K | 0.05% | 149 |
|
|
2024
Q4 | $207K | Buy |
6,127
+30
| +0.5% | +$1.02K | 0.05% | 164 |
|
|
2024
Q3 | $249K | Buy |
6,097
+36
| +0.6% | +$1.47K | 0.06% | 150 |
|
|
2024
Q2 | $233K | Buy |
6,061
+1,056
| +21% | +$40.7K | 0.06% | 150 |
|
|
2024
Q1 | $215K | Buy |
+5,005
| New | +$215K | 0.05% | 164 |
|
|
2019
Q2 | – | Sell |
-200
| Closed | -$8K | – | 279 |
|
|
2019
Q1 | $8K | Hold |
200
| – | – | 0.01% | 322 |
|
|
2018
Q4 | $8K | Hold |
200
| – | – | 0.01% | 299 |
|
|
2018
Q3 | $8K | Hold |
200
| – | – | 0.01% | 319 |
|
|
2018
Q2 | $8K | Sell |
200
-30
| -13% | -$1.2K | 0.01% | 316 |
|
|
2018
Q1 | $9K | Hold |
230
| – | – | 0.01% | 317 |
|
|
2017
Q4 | $8K | Buy |
+230
| New | +$8K | 0.01% | 329 |
|